Pancreatic Cancer Research

ResearcherZhejiang University of TechnologyActive in the last 2 years

Qinglian Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1912-6442; OpenAlex author ID A5102743296. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer. Co-author DOI 10.1021/acsami.4c10404↗
  2. Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. Co-author DOI 10.1002/smll.201602697↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanxiang Jin · 1 shared paper, 2024 · strength 0.31
  2. Qi Zheng Yao · 1 shared paper, 2017 · strength 0.07
  3. Yang Li · 1 shared paper, 2017 · strength 0.07
  4. Youqing Shen · 1 shared paper, 2017 · strength 0.07
  5. Guping Tang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.